Barclays’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $52.7K | Sell |
11,945
-74,440
| -86% | -$402K | ﹤0.01% | 4303 |
|
|
2025
Q4 | $549K | Buy |
86,385
+7,802
| +10% | +$54.3K | ﹤0.01% | 3788 |
|
|
2025
Q3 | $733K | Sell |
78,583
-16,473
| -17% | -$166K | ﹤0.01% | 3566 |
|
|
2025
Q2 | $1.37M | Buy |
95,056
+41,256
| +77% | +$407K | ﹤0.01% | 3122 |
|
|
2025
Q1 | $371K | Sell |
53,800
-25,973
| -33% | -$163K | ﹤0.01% | 3709 |
|
|
2024
Q4 | $423K | Buy |
79,773
+9,701
| +14% | +$53.1K | ﹤0.01% | 3931 |
|
|
2024
Q3 | $256K | Buy |
70,072
+53,472
| +322% | +$168K | ﹤0.01% | 4167 |
|
|
2024
Q2 | $45.3K | Buy |
+16,600
| New | +$55.5K | ﹤0.01% | 4242 |
|
|
2024
Q1 | – | Sell |
-3,750
| Closed | -$5.36K | – | 5428 |
|
|
2023
Q4 | $5.36K | Buy |
+3,750
| New | +$5.22K | ﹤0.01% | 5028 |
|
|
2023
Q1 | – | Sell |
-100,000
| Closed | -$168K | – | 5412 |
|
|
2022
Q4 | $168K | Sell |
100,000
-193,769
| -66% | -$307K | ﹤0.01% | 3944 |
|
|
2022
Q3 | $361K | Hold |
293,769
| – | – | ﹤0.01% | 2874 |
|
|
2022
Q2 | $491K | Buy |
293,769
+86,159
| +42% | +$168K | ﹤0.01% | 2874 |
|
|
2022
Q1 | $511K | Sell |
207,610
-568,691
| -73% | -$1.55M | ﹤0.01% | 2890 |
|
|
2021
Q4 | $2.9M | Sell |
776,301
-180,440
| -19% | -$974K | ﹤0.01% | 2115 |
|
|
2021
Q3 | $6M | Buy |
956,741
+147,437
| +18% | +$1.21M | ﹤0.01% | 1504 |
|
|
2021
Q2 | $7.98M | Buy |
809,304
+774,833
| +2,248% | +$6.76M | 0.01% | 1311 |
|
|
2021
Q1 | $322K | Buy |
34,471
+17,240
| +100% | +$137K | ﹤0.01% | 3459 |
|
|
2020
Q4 | $83K | Sell |
17,231
-5,382
| -24% | -$26.2K | ﹤0.01% | 4210 |
|
|
2020
Q3 | $92K | Sell |
22,613
-3,717
| -14% | -$17.9K | ﹤0.01% | 4301 |
|
|
2020
Q2 | $121K | Buy |
26,330
+12,689
| +93% | +$56.8K | ﹤0.01% | 4389 |
|
|
2020
Q1 | $44K | Sell |
13,641
-27,370
| -67% | -$105K | ﹤0.01% | 5307 |
|
|
2019
Q4 | $177K | Buy |
41,011
+21,519
| +110% | +$76.5K | ﹤0.01% | 5127 |
|
|
2019
Q3 | $77K | Sell |
19,492
-5,157
| -21% | -$22K | ﹤0.01% | 5670 |
|
|
2019
Q2 | $115K | Buy |
24,649
+13,386
| +119% | +$57.1K | ﹤0.01% | 5587 |
|
|
2019
Q1 | $48K | Buy |
11,263
+10,842
| +2,575% | +$39.1K | ﹤0.01% | 5912 |
|
|
2018
Q4 | $1K | Sell |
421
-14,560
| -97% | -$50.6K | ﹤0.01% | 6845 |
|
|
2018
Q3 | $64K | Buy |
14,981
+257
| +2% | +$1.1K | ﹤0.01% | 5915 |
|
|
2018
Q2 | $54K | Sell |
14,724
-49,395
| -77% | -$188K | ﹤0.01% | 5602 |
|
|
2018
Q1 | $269K | Sell |
64,119
-38,795
| -38% | -$203K | ﹤0.01% | 4567 |
|
|
2017
Q4 | $605K | Buy |
102,914
+81,624
| +383% | +$441K | ﹤0.01% | 3603 |
|
|
2017
Q3 | $91K | Sell |
21,290
-55,998
| -72% | -$205K | ﹤0.01% | 4989 |
|
|
2017
Q2 | $295K | Buy |
77,288
+65,471
| +554% | +$207K | ﹤0.01% | 4024 |
|
|
2017
Q1 | $31K | Buy |
11,817
+11,293
| +2,155% | +$32K | ﹤0.01% | 5599 |
|
|
2016
Q4 | $2K | Buy |
524
+344
| +191% | +$935 | ﹤0.01% | 6387 |
|
|
2016
Q3 | $1K | Sell |
180
-3,435
| -95% | -$12.6K | ﹤0.01% | 6465 |
|
|
2016
Q2 | $15K | Buy |
+3,615
| New | +$17.1K | ﹤0.01% | 5402 |
|
Other funds holding NAGE
SW
VCM
TCM
